Predictive Genetic Counseling Service Market Report 2026

The predictive genetic counseling service market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.4 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing awareness of inherited genetic conditions, expansion of genetic testing availability, growing utilization of prenatal screening services, rising demand for family risk assessment, improvements in molecular diagnostic accuracy.

The predictive genetic counseling service market size is expected to see rapid growth in the next few years. It will grow to $6.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for personalized preventive healthcare, rising integration of ai in genetic interpretation, expansion of remote healthcare services, growing focus on early disease prediction, increasing adoption of population-scale genetic screening. Major trends in the forecast period include increasing use of AI-assisted genetic risk assessment, rising adoption of digital counseling platforms, growing demand for preventive genetic screening services, expansion of tele-genetic counseling models, enhanced focus on data-driven risk interpretation.

The rising investments in genetic research are expected to drive the growth of the predictive genetic counseling service market in the coming years. Genetic research involves systematically studying genes and heredity to understand how traits are inherited and how they influence biological functions. Investment in this area is increasing due to advances in genetic sequencing and precision medicine technologies, which accelerate the development of targeted therapies and enhance the efficiency and commercial potential of biomedical research. Such investments support the demand for predictive genetic counseling services by identifying new genetic markers for inherited diseases, thereby increasing the need for professionals to interpret these findings and guide individuals on their health risks. For example, in September 2024, the National Institutes of Health (NIH), a US-based federal medical research agency, awarded $27 million over five years to establish a genomics-enabled learning health system (gLHS) network aimed at integrating genomic information into clinical practice across multiple hospital learning health systems nationwide. Consequently, growing investments in genetic research are driving the expansion of the predictive genetic counseling service market.

Key companies in the predictive genetic counseling service market are focusing on advanced initiatives, such as no-cost genetic counseling services, to promote early risk assessment and informed health decisions. These services provide free consultations to individuals to help them understand their genetic health risks, often supported by public health programs, research initiatives, or charitable organizations. For instance, in May 2023, Vigil Neuroscience Inc., a US-based biotechnology company, launched ALSPAware, a program offering free genetic testing and counseling for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). ALSPAware provides free and confidential testing and counseling for U.S. residents aged 18 and older. The program supports both individuals and healthcare professionals, offering single-gene tests for those with a family history of ALSP and custom gene panels for diagnosing adult-onset neurological disorders. Licensed genetic counselors assist with the testing process and interpretation of results, while the initiative also provides specialized resources to reduce misdiagnosis and improve disease management for people affected by ALSP.

In February 2025, Tempus AI Inc., a US-based health technology company, acquired Ambry Genetics for an undisclosed amount. The acquisition enhances the use of diagnostics and data to support innovative advancements and strengthens the delivery of advanced solutions to healthcare providers, patients, and life sciences companies. Ambry Genetics Corp. is a US-based provider of predictive genetic counseling services.

Major companies operating in the predictive genetic counseling service market are Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Natera Inc., Tempus AI Inc., Fulgent Genetics Inc., Invitae Corporation, Berry Genomics Co. Ltd., Color Genomics Inc., Decode Genetics Inc., Myriad Genetics Inc., Genpath Diagnostics, Genomic Medical Inc., GeneDx Inc., EasyDNA, Blueprint Genetics Inc., Veritas Genetics International Ltd., Abbott Pathology, Bgi Group Ltd.

North America was the largest region in the predictive genetic counseling service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic counseling service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the predictive genetic counseling service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the predictive genetic counseling service market by increasing costs of imported genetic testing kits, sequencing reagents, laboratory instruments, and digital diagnostic infrastructure. Hospitals and clinical laboratories in North America and Europe are most affected due to reliance on imported molecular diagnostics, while Asia-Pacific faces higher service delivery costs in export-oriented testing facilities. These tariffs are raising service pricing and limiting access for cost-sensitive populations. However, they are also driving local diagnostic manufacturing, domestic laboratory expansion, and increased investment in regionally developed genetic testing services.

The predictive genetic counseling service market research report is one of a series of new reports that provides predictive genetic counseling service market statistics, including predictive genetic counseling service industry global market size, regional shares, competitors with a predictive genetic counseling service market share, detailed predictive genetic counseling service market segments, market trends and opportunities, and any further data you may need to thrive in the predictive genetic counseling service industry. This predictive genetic counseling service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Predictive genetic counseling service is a specialized process in which trained professionals assess the likelihood of inherited genetic conditions by analyzing an individual’s family history and genetic background. This service involves interpreting genetic information to evaluate potential health risks, providing individuals with informed insights into their genetic predispositions.

The main categories of predictive genetic counseling services include premarital examination services, parent-child identification services, antenatal examination services, and single-gene or polygenic disease diagnosis services. Premarital examination services involve health assessments conducted before marriage to detect any genetic, infectious, or chronic conditions that could affect either partner or their future children. These services are utilized for both adults and children by a range of end users, including hospitals, clinical laboratories, academic institutions, research organizations, and pharmaceutical companies.

The predictive genetic counseling service market includes revenues earned by entities by providing services such as family history assessment, carrier status interpretation, inheritance pattern explanation, psychosocial support counseling, and risk reduction strategy guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.